This recent article titled by Lavaud et al., uses high-frequency ultrasound and spectroscopic photoacoustic imaging as a multimodal non-invasive examination tool for the assessment of melanoma brain tumors in an orthotropic mouse model.
Metastasis rather than primary tumors determine prognosis and mortality in the majority of cancer patients. Detection of metastatic lesions is critical to determine prognosis and suitable treatments. We developed a method... Read full story.
This recent article by Bruckner et al., uses commercially available target-ready microbubbles and antibodies to non-invasively assess the severity of intestinal inflammation and development of tumors in a mouse model of colitis.
This featured publication by Shirinfard et al, uses a novel microbubbles injection technique to evaluate the feasibility of using dynamic contrast enhanced ultrasound (CEUS) to assess absolute perfusion of tissue in mice.
CRISPR-Cas 9 is a method used to target and edit DNA at precise locations in living cells. This has broad implications in treating human disease, specifically in the field of oncology. Read full blog.
This article by Wilson, et al. uses PA contrast agent with an antibody specific to breast cancer cells to perform in vivo molecular imaging in an orthotopic mouse model of breast cancer.
Molecular Imaging is emerging as an innovative and multidisciplinary field of research aimed at visualizing and quantifying the signature of diseases, making it possible for an earlier and more precise diagnosis. Read more.
Dr. Peng Huang presented his work on the development of a clinically translatable cancer theranostic agent at the World Molecular Imaging Conference in Hawaii. This therapy uses a near-infrared (NIR) cyanine dye and human serum albumin (HSA) conjugate for NIRfluorescence/photoacoustic/thermal multimodality imaging and photothermal tumor ablation. Read more.
This recent article by Freeling et al. highlights the benefits of using Ultra High Frequency (UHF) Ultrasound with 3D Non-linear contrast (NLC) to assess colorectal cancer in a murine model. Read more.
Laurie Rich from Roswell Park Cancer Institute in Buffalo, NY discusses Photoacoustic Imaging (PAI) and its potential for monitoring tumor oxygenation, comparisons to MRI, PAI Sensitivity and its role in predicting tumor response to radiation therapy and so much more!
This recent study by Scheepbouwer et al, highlights the benefits of a multimodal imaging approach by using Bioluminescence (BLI), High Resolution Ultrasound (HRUS) and Photoacoustics (PAI) to image orthotopic tumor proliferation over a 30 day time period.
This recent study by Bar-Zion et al. in the prominent journal, Cancer Research, highlights the significance and validity of contrast-enhanced ultrasound and photoacoustics (PA) to assess vascularity in tumors and to monitor efficacy of treatment dynamically over time.
Join host Dr. Alexadra Eichten of Regeneron Phramaceuticals on this webinar as she discusses utilizing non-invasive imaging modalities to assess effects of VEGF blockade in tumors.
Join Minalini Lakshman as she discusses Preclinical evaluation of lead candidates, tackling translational challenges and next generation cancer therapy.
This webinar is presented by Andrew Needles, Senior Manager, Product Innovation, FUJIFILM, VisualSonics, Inc. This webinar explores the capabilities of the Vevo 3100 Ultrasound Imaging System for preclinical research across cardiovascular, cancer, developmental, abdominal and neurobiology
This webinar is Part 2 of the Webinar hosted by Dr. Walker III. Dr. Walker continues the discussion on a novel 3-dimensional micro-ultrasound approach to automated measurement of carotid arterial plaque volume as a biomarker for experimental atherosclerosis.
